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Abstract
© 2018, © 2018 Taylor & Francis. A library of 29 2-amino-6-sulfanylpyridine-3,5-dicarbonitriles
functionalized with  a  pyridoxine moiety  was synthesized using a  three-component  one-pot
reaction  of  aldehyde  derivative  of  pyridoxine,  malononitrile,  and  thiophenol.  The  obtained
bipyridine  structures  were  converted  into  methylpyridinium  salts.  Several  compounds
demonstrated expressed antibacterial activity with MICs (minimum inhibitory concentrations) in
the range of 0.5–4 µg/mL against the three studied Gram-positive strains and 8–64 µg/mL
against the Gram-negative E. coli strain, which was comparable or better than the activity of the
reference antimicrobial agents. At the same time, all the synthesized compounds were inactive
against the Gram-negative P. aeruginosa. Several compounds also demonstrated high cytotoxic
activity against the studied tumor cells, but without selectivity for the normal HSF (human
foreskin fibroblast) cells. Despite the preliminary character of the performed biological studies,
the obtained results make the obtained structural chemotype a promising starting point for the
design of physiologically active compounds.
http://dx.doi.org/10.1080/00397911.2018.1501487
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